Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. Summary
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
389.95(c) 390.03(c) 398.98(c) 400.19(c) 409.09(c) Last
804 083 428 246 1 010 129 610 413 786 031 Volume
+0.77% +0.02% +2.29% +0.30% +2.22% Change
More quotes
Financials (USD)
Sales 2021 2 341 M - -
Net income 2021 206 M - -
Net Debt 2021 696 M - -
P/E ratio 2021 194x
Yield 2021 -
Sales 2022 2 838 M - -
Net income 2022 309 M - -
Net Debt 2022 560 M - -
P/E ratio 2022 132x
Yield 2022 -
Capitalization 39 561 M 39 561 M -
EV / Sales 2021 17,2x
EV / Sales 2022 14,1x
Nbr of Employees 5 500
Free-Float 98,7%
More Financials
Company
DexCom, Inc. specialises in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 78.3% of net sales. 
More about the company
Ratings of DexCom, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about DEXCOM, INC.
06/11DEXCOM  : Insider Sale at Dexcom (DXCM) Continues Selling Trend
MT
06/11DEXCOM  : British Columbia First Province to Cover Dexcom G6 Continuous Glucose ..
BU
06/10INSIDER TRENDS : Selling By Insiders Lingers at Dexcom
MT
06/07INSIDER TRENDS : Dexcom Insider Continues 90-Day Selling Trend
MT
06/03DEXCOM  : Looks to the Future of Continuous Glucose Monitoring
BU
06/02DEXCOM  : Insider Sale at Dexcom (DXCM) Continues Selling Trend
MT
06/01INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Dexcom
MT
06/01DEXCOM  : Saskatchewan Health to Cover Dexcom G6 Continuous Glucose Monitoring S..
AQ
05/28DEXCOM  : Wells Fargo Upgrades DexCom to Equal-Weight From Underweight; Price Ta..
MT
05/27INSIDER TRENDS : 90-Days of Insider Buying at Dexcom Eased Back with Share Dispo..
MT
05/27DEXCOM  : Announces Upcoming Conference Presentation
BU
05/26INSIDER TRENDS : Dexcom Insider Disposition Scales Back 90-Days of Buys
MT
05/26INSIDER TRENDS : Dexcom Sees 90 Days of Insider Buying Trend Reducing with Share..
MT
05/26DEXCOM  : RAMQ Now Offers Provincial Coverage of The Dexcom G6 Continuous Glucos..
AQ
05/25DEXCOM  : Barclays Initiates Coverage on DexCom With Overweight Rating, $500 Pri..
MT
More news
News in other languages on DEXCOM, INC.
06/11DEXCOM  : La colombie-britannique est la première province à couvrir le système ..
06/04DEXCOM  : explora el futuro de la monitorización continua de la glucosa
06/04DEXCOM  : richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessu..
06/03DEXCOM  : kijkt naar de toekomst van continue glucosemonitoring
06/03DEXCOM  : esplora il futuro del monitoraggio glicemico in continuo
More news
Analyst Recommendations on DEXCOM, INC.
More recommendations
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 464,95 $
Last Close Price 409,09 $
Spread / Highest target 32,0%
Spread / Average Target 13,7%
Spread / Lowest Target -35,7%
EPS Revisions
Managers and Directors
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Jereme M Sylvain SVP-Finance, Chief Financial & Accounting Officer
Andrew K. Balo EVP-Clinical Affairs, Regulatory Strategy
Jacob S. Leach Chief Technology Officer & Executive VP
Shelly R. Selvaraj Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.10.65%39 561
ABBOTT LABORATORIES0.90%195 290
MEDTRONIC PLC5.98%166 534
BECTON, DICKINSON AND COMPANY-3.00%70 564
ALIGN TECHNOLOGY, INC.13.36%48 395
HOYA CORPORATION-1.68%46 812